MAPI Research Trust provides reliable, comprehensive and up-to-date information services to research scientists, pharmaceutical companies, and governmental health agencies involved in the fields of Patient-Reported Outcomes (PRO) and Epidemiology worldwide.
Home SERVICES Questionnaire Licensing Our Catalog MOS-HIV (Medical Outcome Study-HIV Health Survey)

Developed by:
Albert Wu (USA)

Objective:
To evaluate patient outcomes in clinical trials and other studies of people with HIV/AIDS

Copyright:
Copyright © 1996 The Johns Hopkins University/Albert Wu, MD, MPH. All Rights Reserved.

Reference publications:
Wu AW, Rubin HR, Mathews WC, Ware JE, Brysk LT, Hardy WD, Bozzette SA, Spector SA, Richman DD. A health status questionnaire using 30 items from the Medical Outcomes Study: Preliminary validation in persons with early HIV infection. Medical Care 1991; 29(8):786-798

Revicki DA, Sorensen S, Wu AW. Reliability and validity of physical and mental health summary scores from the Medical Outcomes Study HIV Health Survey. Med Care 1998; 36:126-37

Wu AW, Revicki DA, Jacobson D, Malitz FE. Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Qual Life Res 1997; 6:481-93


Conditions of use:

1. User Agreement:
User is required to complete and sign a User Agreement in which specific conditions requested by the Author are detailed.


2. Access fees:

carre6 Author's royalty fees:
The use of the MOS-HIV in commercial studies (1) is subject to the Author's royalty fees, of an amount of 5,000 €* per protocol/application.

Other specific conditions requested by the Author are detailed in the User Agreement.

carre6 Distribution fees are requested according to the study design and context of use of the questionnaire:
  1. In academic research  and individual clinical practice: : free of charge
  2. In commercial studies involving "for-profit" organizations (1): 1,200 €* per study plus an additional 250 €* per language version requested.


* excluding VAT

(1) Commercial studies (industry, CRO, any for-profit companies).


Existing translations:

The MOS-HIV has been developped in US English and is available in the following languages:

Argentina (Spanish)* Australia/New Zealand (English)* Belgium (Dutch)*
Brazil (Portuguese)* Canada (English)* Canada (French)*
Denmark (Danish)* France (French)* Germany (German)*
Italy (Italian)* Mexico (Spanish)* Netherlands (Dutch)*
Portugal (Portuguese)* South Africa (English)* Spain (Spanish)*
Sweden (Swedish)* United Kingdom (English)* United States (Spanish
     
* translations produced for the IQOLA project  


Please contact MAPI Research Trust for the conditions to access the IQOLA translations.

Academic local translations may also be available at MAPI Research Trust. Please contact our Information Center to check the availability of the language versions and for additional information.


New translations:

For the production of new translations to be used in commercial studies, each translation shall be coordinated by MAPI Institute.


Review copy:

US English version available for review purpose only. Please click here to access.


Contact information:

MAPI Research Trust

27 rue de la Villette
F - 69003 LYON
Tel: +33 4 72 13 65 75
Fax: +33 4 72 13 55 73
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Please have the User Agreement completed, dated and signed and return one original copy to MAPI Research Trust by post. As soon as we receive it, we will process your request.


More information on the MOS-HIV on PROQOLID


[ BACK ]
 

2012 05 18

To access our catalog, please click here.

 

New questionnaires distributed by MAPI Research Trust

ACCEPT (Chronic Treatment Acceptance Questionnaire)
Registrat MAPI (France) and MAPI Consultancy

ADRQL (Alzheimer Disease Related Quality of Life)
Black Betty S, Kasper Judith D and Rabins Peter V. - Johns Hopkins Medical INstitutions (USA)

Barthel Index
Florence I. Mahoney and Dorothea W. Barthel.

ESS (Epworth Sleepiness Scale)
Murray W. Johns (Australia)

FIRST (Fibromyalgia Rapid Screening Tool)
Serge Perrot & Didier Bouhassira (France)

PDSS-2 (Parkinson's Disease Sleep Scale)
Ray Chaudhuri (UK), Claudia Trenkwalder (Germany), Ralf Kohnen (Germany)

Skindex questionnaire 
Mary-Margaret Chren (USA)

TRIM-D and TRIM-D Device (Treatment Related Impact Measure for Diabetes)
Novo Nordisk (Denmark)